Conor McCarthy


Conor is a partner in the firm’s Corporate and M&A Department.

Conor advises public and private industry-leading Irish and international companies on all aspects of company law. He advises clients on a wide range of corporate transactions including mergers and acquisitions, joint ventures, corporate finance transactions, cross border mergers, corporate reorganisations and general corporate/commercial law advice. Conor also specialises in equity capital markets transactions.

Conor has advised on some of the most high profile Irish M&A and equity capital markets transactions in recent years. Conor joined the firm in 2014 from Linklaters LLP in London.


  • Advised Strongbridge Biopharma plc on the €145 million sale of its rights to Macrilen in the United States and Canada to Novo Nordisk
  • Advised CRH plc on its €1 billion ordinary share buy-back programme
  • Advised financial institutions on the transfer of their European banking business from the United Kingdom to Ireland (via cross-border merger)
  • Advised Aryzta A.G. on its €800 million underwritten rights issue and the resulting admission of shares on the SIX Swiss Exchange and Euronext Dublin
  • Advised Bank of Cyprus on its holding company reorganisation using an Irish holding company and EUR 1.45 billion flotation on the LSE and CSE
  • Advised Bank of Ireland on its holding company reorganisation using a new Irish holding company and its flotation on the ISE and LSE
  • Advised CRH on its €6.5 billion acquisition of assets from Lafarge S.A. and Holcim Limited in 12 jurisdictions
  • Advised CRH on €1.6 billion “cashbox” placing to raise funds for the acquisition of certain assets from Lafarge S.A. and Holcim Limited
  • Advised CRH plc on various of its domestic and global acquisitions and disposals
  • Advised eir on its €3.5 billion sale to NJJ
  • Advised eir on GIC’s acquisition of €230 million minority holding in eir
  • Advised TE Connectivity on its $895 million acquisition of Creganna
  • Advised Mallinckrodt plc on its $5.8 billion acquisition of Questcor Pharmaceuticals Inc.
  • LL B, Trinity College Dublin, 2007
  • Admitted as a solicitor in England and Wales, 2011 (currently non-practising)
  • Admitted as a solicitor in Ireland, 2014
  • Law Society of England and Wales
  • Law Society of Ireland